MIAMI, FL -- (Marketwire) -- 09/16/09 -- Stock Market Alert's performance stock list includes: Sunwin International Neutraceuticals, Inc. (OTCBB: SUWN), Pfizer Inc. (NYSE: PFE), BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) and Merck & Co., Inc. (NYSE: MRK).
Sunwin International Neutraceuticals, Inc. will certainly have the attention of investors this morning. The company has just announced that it now has 500 metric tons of annual high-grade Stevia production capacity, due to newly converted facilities.
The company, a leader in the production and distribution of Chinese herbs, veterinary medicines and one of the world's leading producers of all natural, zero calorie stevia in China, acquired 100% interest of Qufu Shengren in April 2009 and began the conversion of the facilities to produce high grade stevia extracts. The completion of this conversion comes at a time when Sunwin is poised to enter its stevia extracts for use as a sweetener in the U.S. food and beverage industry with the completion of the process for U.S. Food and Drug Administration ("FDA") self-affirmed GRAS status for stevia extracts produced by Sunwin.
Chairman Laiwang Zhang stated, "This additional production is critical as we enter the U.S. markets and build on our strategic partnership with WILD Flavors Inc. Management has been committed to broadening our stevia production capabilities as we jointly develop numerous formulations and products using our stevia extracts that are healthy and great tasting. We have never been more excited about the future prospects for Sunwin and we intend to aggressively pursue the vast opportunities in front of us."
The stock closed yesterday at around Twenty Six cents a share a share.
For an in-depth profile of Sunwin International Neutraceuticals, visit http://wallstreetenews.com/view-company-profiles.php?profile=SUWN_072909.
Pfizer Inc. (NYSE: PFE) down 0.9% on 40.1 million shares traded. Pfizer Inc., founded in 1849, is dedicated to better health and greater access to health care for people and their valued animals.
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) up 8.7% on 10.2 million shares traded. BioCryst Pharmaceuticals designs, optimizes and develops novel small-molecule pharmaceuticals that block key enzymes involved in infectious diseases, cancer, and inflammatory diseases.
Merck & Co., Inc. (NYSE: MRK) down 0.5% on 15.2 million shares traded. Merck & Co., Inc. is a global research-driven pharmaceutical company dedicated to putting patients first.
This advertisement is provided by Wall Street Enews, a division of Stock Market Alerts LLC, an electronic broadcaster and publisher of this release, and hereafter referred to as "the company." The company also maintains a contractual, working relationship with Wall Street Capital Funding LLC. and its Wall Street News Alert brand. For current services performed for Sunwin International Neutraceuticals, Inc. (OTCBB: SUWN), China Direct Industries, Inc. ("China Direct Industries"), Dragon Capital Group Corp, China America Holdings, China Armco Metals, Inc. and Dragon International Group Corp., the company has been compensated a total of Three Hundred Thousand Dollars (Two Hundred and Fifty Thousand dollars for current services and Fifty Thousand dollars for previous services) by China Direct Investments Inc., a Florida corporation, and a wholly owned subsidiary of China Direct. The company does not hold any shares of the stock. Because the company received compensation for its services, there is an inherent conflict of interest in the company statements and opinions and such statements and opinions cannot be considered independent.
The information contained in this press release is for informational purposes only, and not to be construed as an offer to sell or solicitation of an offer to buy any security. The company makes no representation or warranty relating to the validity of the facts presented nor does the company represent or warrant that all material facts necessary to make an investment decision are presented above. Stock Market Alerts LLC is an advertising company and therefore, this release should be viewed for informational purposes only.
The company relies exclusively on information gathered on the public company, such as public filings, press releases and its web sites. Investors should use the advertising information contained in this release as a starting point for conducting additional research on the public company in order to allow the investor to form his or her own opinion regarding the public company. Factual statements contained in this publication are made as of the date stated and they are subject to change without notice. The company is not a registered investment adviser, broker or a dealer.
Investing in the public company that this release is providing service for should be reviewed as speculative and a high-risk and may result in the loss of some or all of any investment.
This release may contain statements that constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended. The words "may," "would," "will," "expect," "estimate," "anticipate," "believe," "intend," and similar expressions and variations thereof are intended to identify forward-looking statements.